Lijuan Guo

Pterostilbene inhibits hepatocellular carcinoma proliferation and HBV replication by targeting ribonucleotide reductase M2 protein.

Weiliang Zhu, H. Yao, Tingjun Hou, 2021, American journal of cancer research.

Data-independent acquisition strategy for the serum proteomics of tuberculosis

L. Zhong, Lijuan Guo, Huifang Tian, 2017 .

Decreased serum miR-181a is a potential new tool for breast cancer screening.

Lijuan Guo, Qing-Yun Zhang, 2012, International journal of molecular medicine.

Super-enhancers and novel therapeutic targets in colorectal cancer

Qian Liu, Lijuan Guo, J. Shao, 2022, Cell Death & Disease.

Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA.

Jian-xin Gao, Lijuan Guo, Qingyun Zhang, 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer

Chen Li, H. Qi, Yongfeng Ding, 2021, Cell Death & Disease.

E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinoma

Lijuan Guo, Zejun Fang, Yuanling Xu, 2023, Biochemical Pharmacology.